Brain alpha-synuclein accumulation in multiple system atrophy, Parkinson's disease and progressive supranuclear palsy: a comparative investigation (Q43244813)

From Wikidata

Jump to navigation Jump to search

scientific article published on 10 November 2009

Language	Label	Description	Also known as
English	Brain alpha-synuclein accumulation in multiple system atrophy, Parkinson's disease and progressive supranuclear palsy: a comparative investigation	scientific article published on 10 November 2009

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

Brain alpha-synuclein accumulation in multiple system atrophy, Parkinson's disease and progressive supranuclear palsy: a comparative investigation (English)

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

Parkinson's disease

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

multiple system atrophy

1 reference

based on heuristic

inferred from title

progressive supranuclear palsy

1 reference

based on heuristic

inferred from title

Oleh Hornykiewicz

10

object named as

Oleh Hornykiewicz

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

author name string

Junchao Tong

1

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

Henry Wong

2

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

Mark Guttman

3

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

Lee C Ang

4

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

Lysia S Forno

5

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

Mitsunobu Shimadzu

6

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

Ali H Rajput

7

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

Manfred D Muenter

8

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

Stephen J Kish

9

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

Yoshiaki Furukawa

11

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

language of work or name

0 references

publication date

10 November 2009

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

133

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

Pt 1

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

172-188

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

New insights into progressive supranuclear palsy

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWP282

21 January 2018

Phosphorylation of Ser-129 is the dominant pathological modification of alpha-synuclein in familial and sporadic Lewy body disease

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWP282

21 January 2018

The dorsal motor nucleus of the vagus is not an obligatory trigger site of Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWP282

21 January 2018

Red blood cells are the major source of alpha-synuclein in blood.

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWP282

21 January 2018

Analysis of gene expression in Parkinson's disease: possible involvement of neurotrophic support and axon guidance in dopaminergic cell death

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWP282

21 January 2018

Staging of brain pathology related to sporadic Parkinson's disease

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWP282

21 January 2018

Development of alpha-synuclein immunoreactive astrocytes in the forebrain parallels stages of intraneuronal pathology in sporadic Parkinson's disease

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWP282

21 January 2018

A critical evaluation of the Braak staging scheme for Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWP282

21 January 2018

The solubility of alpha-synuclein in multiple system atrophy differs from that of dementia with Lewy bodies and Parkinson's disease

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWP282

21 January 2018

Levels of alpha-synuclein mRNA in sporadic Parkinson disease patients

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWP282

21 January 2018

Co-association of parkin and alpha-synuclein

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWP282

21 January 2018

Comparative study of commercially available anti-alpha-synuclein antibodies

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWP282

21 January 2018

Non-Abeta component of Alzheimer's disease amyloid (NAC) revisited. NAC and alpha-synuclein are not associated with Abeta amyloid.

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWP282

21 January 2018

Biochemical staging of synucleinopathy and amyloid deposition in dementia with Lewy bodies.

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWP282

21 January 2018

Mitochondrial import and accumulation of alpha-synuclein impair complex I in human dopaminergic neuronal cultures and Parkinson disease brain

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWP282

21 January 2018

Widespread alterations of alpha-synuclein in multiple system atrophy

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWP282

21 January 2018

Immunohistochemical and biochemical studies demonstrate a distinct profile of alpha-synuclein permutations in multiple system atrophy

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWP282

21 January 2018

Novel antibodies to synuclein show abundant striatal pathology in Lewy body diseases

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWP282

21 January 2018

Comparison of kindreds with parkinsonism and alpha-synuclein genomic multiplications

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWP282

21 January 2018

Genetic variability in the SNCA gene influences α-synuclein levels in the blood and brain

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWP282

21 January 2018

Brain biopterin and tyrosine hydroxylase in asymptomatic dopa-responsive dystonia

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWP282

21 January 2018

Brain proteasomal function in sporadic Parkinson's disease and related disorders

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWP282

21 January 2018

Consensus statement on the diagnosis of multiple system atrophy.

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWP282

21 January 2018

Lewy body diseases and multiple system atrophy as alpha-synucleinopathies

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWP282

21 January 2018

Elevated alpha-synuclein mRNA levels in individual UV-laser-microdissected dopaminergic substantia nigra neurons in idiopathic Parkinson's disease

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWP282

21 January 2018

Widespread occurrence of argyrophilic glial inclusions in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWP282

21 January 2018

The precursor protein of non-A beta component of Alzheimer's disease amyloid is a presynaptic protein of the central nervous system

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWP282

21 January 2018

Identification of two distinct synucleins from human brain

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWP282

21 January 2018

Alpha-synuclein pathology in Parkinson's and Alzheimer's disease brain: incidence and topographic distribution--a pilot study

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWP282

21 January 2018

A critical reappraisal of current staging of Lewy-related pathology in human brain

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWP282

21 January 2018

Hyperphosphorylation and insolubility of alpha-synuclein in transgenic mouse oligodendrocytes

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWP282

21 January 2018

Selective insolubility of alpha-synuclein in human Lewy body diseases is recapitulated in a transgenic mouse model

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWP282

21 January 2018

The dorsal motor nucleus of the vagus is not an obligatory trigger site of Parkinson's disease: a critical analysis of alpha-synuclein staging

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWP282

21 January 2018

Alteration in alpha-synuclein mRNA expression in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWP282

21 January 2018

Uneven pattern of dopamine loss in the striatum of patients with idiopathic Parkinson's disease. Pathophysiologic and clinical implications

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWP282

21 January 2018

Clinical and biochemical correlates of insoluble alpha-synuclein in dementia with Lewy bodies

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWP282

21 January 2018

Nigral burden of alpha-synuclein correlates with striatal dopamine deficit

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWP282

21 January 2018

Presynaptic alpha-synuclein aggregates, not Lewy bodies, cause neurodegeneration in dementia with Lewy bodies.

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWP282

21 January 2018

Novel alpha-synuclein-immunoreactive proteins in brain samples from the Contursi kindred, Parkinson's, and Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWP282

21 January 2018

Aggregation promoting C-terminal truncation of alpha-synuclein is a normal cellular process and is enhanced by the familial Parkinson's disease-linked mutations

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWP282

21 January 2018

A precipitating role for truncated alpha-synuclein and the proteasome in alpha-synuclein aggregation: implications for pathogenesis of Parkinson disease

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWP282

21 January 2018

The rat brain synucleins; family of proteins transiently associated with neuronal membrane

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWP282

21 January 2018

Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWP282

21 January 2018

DJ-1 is present in a large molecular complex in human brain tissue and interacts with alpha-synuclein

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWP282

21 January 2018

Alpha-synuclein in blood and brain from familial Parkinson disease with SNCA locus triplication

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWP282

21 January 2018

Direct quantification of CSF alpha-synuclein by ELISA and first cross-sectional study in patients with neurodegeneration

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWP282

21 January 2018

Hereditary form of parkinsonism--dementia

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWP282

21 January 2018

Detection of elevated levels of soluble alpha-synuclein oligomers in post-mortem brain extracts from patients with dementia with Lewy bodies.

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWP282

21 January 2018

Expression of alpha-synuclein mRNA in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWP282

21 January 2018

Glial cytoplasmic inclusions in the CNS of patients with multiple system atrophy (striatonigral degeneration, olivopontocerebellar atrophy and Shy-Drager syndrome).

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWP282

21 January 2018

The distribution of oligodendroglial inclusions in multiple system atrophy and its relevance to clinical symptomatology

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWP282

21 January 2018

Alpha-synuclein pathology does not predict extrapyramidal symptoms or dementia

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWP282

21 January 2018

Applicability of current staging/categorization of alpha-synuclein pathology and their clinical relevance

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWP282

21 January 2018

Novel monoclonal antibodies demonstrate biochemical variation of brain parkin with age.

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWP282

21 January 2018

Epitope mapping and specificity of the anti-alpha-synuclein monoclonal antibody Syn-1 in mouse brain and cultured cell lines

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWP282

21 January 2018

Aβ deposition is associated with enhanced cortical α-synuclein lesions in Lewy body diseases

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWP282

21 January 2018

Mutation in the alpha-synuclein gene identified in families with Parkinson's disease

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWP282

21 January 2018

Alpha B-crystallin is a major component of glial cytoplasmic inclusions in multiple system atrophy.

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWP282

21 January 2018

Altered expression of the synuclein family mRNA in Lewy body and Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWP282

21 January 2018

Ubiquitination of alpha-synuclein is not required for formation of pathological inclusions in alpha-synucleinopathies

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWP282

21 January 2018

The formation of highly soluble oligomers of alpha-synuclein is regulated by fatty acids and enhanced in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWP282

21 January 2018

Expression of Lewy body protein septin 4 in postmortem brain of Parkinson's disease and control subjects

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWP282

21 January 2018

alpha-Synuclein locus triplication causes Parkinson's disease

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWP282

21 January 2018

Aggregated and monomeric alpha-synuclein bind to the S6' proteasomal protein and inhibit proteasomal function

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWP282

21 January 2018

Filamentous alpha-synuclein inclusions link multiple system atrophy with Parkinson's disease and dementia with Lewy bodies

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWP282

21 January 2018

alpha-Synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with lewy bodies

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWP282

21 January 2018

Alpha-synuclein in Lewy bodies

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWP282

21 January 2018

Ubiquitination of alpha-synuclein in Lewy bodies is a pathological event not associated with impairment of proteasome function

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWP282

21 January 2018

Brain dopamine-stimulated adenylyl cyclase activity in Parkinson's disease, multiple system atrophy, and progressive supranuclear palsy

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWP282

21 January 2018

Proposed neuropathological criteria for the post mortem diagnosis of multiple system atrophy.

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWP282

21 January 2018

Lewy bodies are not increased in progressive supranuclear palsy compared with normal controls

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWP282

21 January 2018

Glial cytoplasmic inclusions in white matter oligodendrocytes of multiple system atrophy brains contain insoluble alpha-synuclein.

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWP282

21 January 2018

Lewy bodies in progressive supranuclear palsy represent an independent disease process

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWP282

21 January 2018

Molecular cloning of cDNA encoding an unrecognized component of amyloid in Alzheimer disease

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWP282

21 January 2018

Convergence of heat shock protein 90 with ubiquitin in filamentous alpha-synuclein inclusions of alpha-synucleinopathies

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWP282

21 January 2018

NACP, a presynaptic protein, immunoreactivity in Lewy bodies in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWP282

21 January 2018

Alpha-synuclein immunoreactivity in glial cytoplasmic inclusions in multiple system atrophy

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWP282

21 January 2018

Autosomal dominant Lewy body parkinsonism in a four-generation family

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWP282

21 January 2018

Characterization of antibodies that selectively detect alpha-synuclein in pathological inclusions

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWP282

21 January 2018

NACP, a protein implicated in Alzheimer's disease and learning, is natively unfolded

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWP282

21 January 2018

Differential changes in neurochemical markers of striatal dopamine nerve terminals in idiopathic Parkinson's disease

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWP282

21 January 2018

Dopamine-dependent neurotoxicity of alpha-synuclein: a mechanism for selective neurodegeneration in Parkinson disease

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWP282

21 January 2018

Patterns and stages of alpha-synucleinopathy: Relevance in a population-based cohort.

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWP282

21 January 2018

Accumulation of Insoluble α-Synuclein in Dementia with Lewy Bodies

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWP282

21 January 2018

Distinctive neuropathology revealed by α-synuclein antibodies in hereditary parkinsonism and dementia linked to chromosome 4p

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWP282

21 January 2018

Identifiers

10.1093/BRAIN/AWP282

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43244813&oldid=1984732790"